Literature: open-access stability study

Sitagliptin 10 mg/mL (1% w/v sitagliptin phosphate) oral solution

Ingredients

IngredientRoleFor 100 mL
Sitagliptin phosphate monohydrateactive1 g
Sorbitol solution 70%sweetener21.9 mL
Mannitolsweetener2.19 g
Strawberry flavor powderflavor0.63 g
Purified watervehicleq.s. to 100 mL
Strength
10 mg/mL (1% w/v sitagliptin phosphate)
Starting material
Sitagliptin phosphate monohydrate bulk powder
Container
See the study
  • Amounts per 100 mL scaled from the study's 640 mL batch.

Amounts are ClinDose's arithmetic from the study's concentration; follow the study for the method.

Storage and beyond-use date

StorageBUDBasis
Room temperature28 daysCited stability study. Duration supported by the cited stability study for this formula, container, and storage.

Only the storage conditions the source covers are listed. Use the BUD assistant for other cases. The BUD may not be later than any component's expiration date. Verify against the current official USP chapter.

Ingredient checks

No FDA compounding list or NIOSH flags for the active ingredient.

Source

Zaid AN, Abu Zaaror Y, Kaddumi A, et al.. Stability of extemporaneously prepared sitagliptin phosphate solution. PLoS One. 2022;17(3):e0262068. PMID 35294449. PMC8926268. License: CC BY (checked 2026-11-06). Read the article · DOI

For licensed clinicians. Use with clinical judgment.